期刊文献+

线性探针技术在耐多药结核病诊断中的应用评价 被引量:3

Application and evaluation of line probe assay in the diagnosis of multidrug-resistant tuberculosis
下载PDF
导出
摘要 目的评价线性探针技术诊断临床耐多药结核病(MDR-TB)的价值。方法收集临床分离的结核分枝杆菌菌株268例,采用比例法药敏试验和线性探针技术检测利福平和异烟肼的耐药性,以比例法药敏试验为金标准,分析线性探针方法检测的敏感度、特异度。结果与比例法药敏试验相比,线性探针技术检测耐利福平敏感度为88.89%,特异度为98.05%,耐药检出率差异无统计学意义(χ^2=0.82,P〉0.05);耐异烟肼敏感度为84.61%,特异度为97.69%,耐药检出率差异无统计学意义(χ^2=0.69,P〉0.05);诊断MDR-TB的敏感度为78.26%,特异度为96.85%,耐多药检出率差异无统计学意义(χ^2=0.53,P〉0.05)。结论线性探针技术敏感度和特异度高,可用于MDR-TB的早期诊断。 Objective To evaluate the application value of line probe assay in the diagnoses of multidrug-resistant tuberculosis(MDR-TB).Methods 268 strains of clinically isolated M.tuberculosis were collected.The ratio method drug susceptibility test and line probe assay were adopted for detecting the resistance of rifampin(RFP)and isoniazid(INH).Using the ratio method of the drug susceptibility test as gold standard,the sensitivity and specificity of line probe assay were analyzed and compared with those by the traditional drug susceptibility test.Results Conpared with the ratio method drug susceptibility test,the sensitivity and specificity of the line probe assay were88.89% and 98.05%for detecting RIF resistance and 84.61%and 97.69%for detecting INH resistance,respectively,there was no statistically significant difference between the two methods(χ~2=0.82,P0.05;χ~2=0.69,P0.05).The sensitivity and specificity of line probe assay for diagnosing MDR-TB detecting were 78.26% and96.85% respectively,the difference in multiple drug resistance rate had no statistical significance(χ~2=0.53,P0.05).Conclusion The line probe assay is a reliable method with high sensitivity and high specificity and can be used for the early diagnosis of MDR-TB.
出处 《检验医学与临床》 CAS 2016年第10期1336-1338,共3页 Laboratory Medicine and Clinic
关键词 结核分枝杆菌 耐多药结核病 线性探针技术 药敏试验 M tuberculosis multidrug resistance tuberculosis line probe assay drug susceptibility test
  • 相关文献

参考文献10

  • 1王黎霞,成诗明,陈明亭,赵雁林,张慧,姜世闻,何广学,吕青,杜昕,陈伟,刘小秋,阮云洲,王胜芬,夏愔愔,于兰,李峻,李雪,王宇,无.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508. 被引量:2447
  • 2Prasad R, Gupta N, Singh M. Multidrug resistant tubercu- losis trends and control[J]. Indian J Chest Dis Allied Sci, 2014,56 (4) : 237-246.
  • 3张贺秋,赵雁林.现代结核病诊断技术[M].北京:人民卫生出版社,2013: 50-56.
  • 4Ezati N,Lukoye D,Wampande EM,et al. The Mycobacte- rium tuberculosis Uganda lI family and resistance tofirst-line anti-tuberculosis drugs in Uganda[J]. BMC In- fect Dis,2014,14(1) :703.
  • 5Ali IF, Babak F, Fazlollah MS, et al. Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR SSCP from clinical Specimens[J]. Asian Pac J Trop Bi- omed,2014,4(1) : 165-170.
  • 6赵雁林,王黎霞.结核分枝杆菌药物敏感性试验标准化操作程序及质量保证手册[M].北京:人民卫生出版社,2013.
  • 7Imperiale BR, Di Giulio AB, Adricln Cataldi A, et al. Eval- uation of Mycobacterium tuberculosis cross resistance to isoniazid,rifampicin and levofloxacin with their respective structural analogs[J]. J Antibiot ( Tokyo), 2014,67 ( 11 ) .. 749-754.
  • 8李强,欧喜超,夏辉,赵冰,赵雁林.Genotype MTBDRplus快速耐药诊断方法在地市级结核病医院应用的评估研究[J].中国预防医学杂志,2013,14(1):35-38. 被引量:16
  • 9Mitarai S, Kato S, Ogata H, et al. Comprehensive multi center evaluation of a new line probe assay kit for identi fication of Mycobacterium speciesand detection of drug resistant Mycobaeterium tuberculosis[J]. J Clin Microbi ol,2012,50(3) 844-890.
  • 10李强,夏辉,欧喜超,赵冰,逄宇,赵雁林.应用线性探针技术与传统药敏试验检测耐药结核病的成本比较[J].中国防痨杂志,2013,35(3):187-190. 被引量:22

二级参考文献37

  • 1中华人民共和国卫生部.WS288-2008肺结核诊断标准.北京:人民卫生出版社,2008.
  • 2中华人民共和国国家统计局.北京:中国统计年鉴2010.[M].中国统计出版社,2010.
  • 3中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 4中华人民共和国卫生部.2000年全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,2002.
  • 5中华人民共和国卫生部.1979全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,1981.
  • 6中华人民共和国卫生部.1984/1985全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,1988.
  • 7中华人民共和国国务院办公厅国办发[2001]75号.国务院办公厅关于印发全国结核病防治规划(2001-2010年)的通知.2001-11-13.
  • 8中华人民共和国国家统计局.第一次全国经济普查主要数据公报(第一号)[EB/OL].2010[2012-06-12]at:http://www.stats.gov.cn/zjpc/cgfb/t20051206-402294807.htra.
  • 9中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版).北京:中国协和医科大学出版社,2009.
  • 10World Health Organization. Policy guidance on drug-suscepti- bility testing (DST) of second-line anti-tuberculosis drugs. Geneva:WHO, 2008.

共引文献2501

同被引文献26

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部